Period-Dependent Survival Benefit of Percutaneous Microwave Ablation for Hepatocellular Carcinoma: A 12-Year Real-World, Multicentric Experience

INTRODUCTION: Although microwave ablation (MWA) is a promising technique for hepatocellular carcinoma (HCC) treatment, its 10-year efficacy is unknown. OBJECTIVE: The objective of the study was to assess whether the advances in MWA for HCC translated into a real-world survival benefit. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jie, Cheng, Zhi-Gang, Han, Zhi-Yu, Liu, Fang-Yi, Zheng, Rong-Qin, Cheng, Wen, Wei, Qiang, Yu, Song-Yuan, Li, Qin-ying, He, Guang-zhi, Luo, Yan-chun, Yu, Xiao-Ling, Liang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294937/
https://www.ncbi.nlm.nih.gov/pubmed/35978603
http://dx.doi.org/10.1159/000522134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294937/
https://www.ncbi.nlm.nih.gov/pubmed/35978603
http://dx.doi.org/10.1159/000522134

Ejemplares similares